Insider Selling: NeueHealth, Inc. (NYSE:NEUE) CEO Sells $91,337.40 in Stock

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 13,180 shares of the firm’s stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total transaction of $91,337.40. Following the completion of the transaction, the chief executive officer now directly owns 297,790 shares in the company, valued at approximately $2,063,684.70. The trade was a 4.24 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

George Lawrence Mikan III also recently made the following trade(s):

• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total transaction of $11,324.24.
• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The stock was sold at an average price of $7.19, for a total value of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Price Performance

Shares of NEUE stock opened at $5.06 on Friday. The company has a market capitalization of $41.93 million, a price-to-earnings ratio of -0.10 and a beta of 0.56. The company’s fifty day moving average price is $7.26 and its 200-day moving average price is $6.01. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $7.66.

Institutional Investors Weigh In On NeueHealth

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Partners Group Holding AG purchased a new stake in shares of NeueHealth during the third quarter worth about $463,000. Northern Trust Corp boosted its stake in NeueHealth by 66.8% in the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after purchasing an additional 13,074 shares during the period. Finally, Virtu Financial LLC purchased a new stake in NeueHealth during the 4th quarter valued at approximately $76,000. 63.88% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada cut their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research note on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.